Library / Laws / 116th Congress / Senate Bills / S. 102
S. 102
To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2019-01-10 | 19.2K | ⠃⠗⠋ |